TRENDS IN THE BURDEN OF CARDIOVASCULAR DISEASES IN THE UK, 1961 TO 2011 by Bhatnagar, P, Scarborough, P, Wickramasinghe, K

Saving lives, improving mothers’ care core report. Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2018-2...

“…In addition, it also includes Confidential Enquiries into the care of women who died between 2018 and 2020 in the UK and Ireland from cardiovascular causes, hypertensive disorders, early pregnancy disorders and accidents and the care of women who died from mental-health related causes in 2020. …”

Excess weight, physical activity, and lifestyle changes during COVID-19 among Young Lives Study participants in Peru by Curi-Quinto, K, Lago, N, Hidalgo, A, Sánchez, A, Penny, M, Cueto, S

“…These are the most important risk factors for non-communicable diseases such as diabetes, hypertension and cardiovascular disease which are growing public health concerns in Peru and worldwide.…”

Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study by Gould, DW, Doidge, J, Sadique, MZ, Borthwick, M, Hatch, R, MacEwen, C, Young, JD, Watkinson, P

“…Secondary outcomes – mortality at hospital discharge, 30 days and 1 year; days of renal, cardiovascular and advanced respiratory support in intensive care unit; length of stay in intensive care unit and hospital; bleeding and thromboembolic events; prevalence of end-stage renal disease at 1 year; and estimated lifetime incremental net monetary benefit.…”

Face-to-face interventions for promoting physical activity. by Richards, J, Hillsdon, M, Thorogood, M, Foster, C

“…The effect of interventions on cardiovascular fitness at one year (two studies; 349 participants) was positive and moderate with no significant heterogeneity in the observed effects (SMD 0.50; 95% CI 0.28 to 0.71; moderate quality evidence). …”

Prospective multicentre randomised, double-blind, equivalence study comparing clonidine and midazolam as intravenous sedative agents in critically ill children: the SLEEPS (Safety... by Wolf, A, McKay, A, Spowart, C, Granville, H, Boland, A, Petrou, S, Sutherland, A, Gamble, C

“…Rebound hypertension did not appear to be a significant problem with clonidine but, owing to its effects on heart rate, specific cardiovascular attention needs to be taken during the loading and early infusion phase. …”